dailyreporter.esmo.org·5 min read·hard
Rethinking cancer vaccines through the tumour immunopeptidome
✦AI Summary
Researchers are advancing cancer vaccine development by utilizing immunopeptidome analysis to identify specific tumor-derived antigens. This approach aims to create more effective, personalized immunotherapies by targeting the unique mutational profiles of individual patients.
Direct identification of specific tumour-derived HLA-bound peptide targets is enabling the development of personalised immunotherapy strategies
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in